Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

22.30
-0.6150-2.68%
Volume:362.54K
Turnover:8.26M
Market Cap:385.73M
PE:-2.34
High:23.19
Open:23.02
Low:22.20
Close:22.91
Loading ...

FDA Grants Fast Track Designation to Nektar Therapeutics' Rezpegaldesleukin for Severe Alopecia Areata Treatment

Reuters
·
29 Jul

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata

THOMSON REUTERS
·
29 Jul

Nektar call volume above normal and directionally bullish

TIPRANKS
·
16 Jul

H.C. Wainwright Reaffirms Their Buy Rating on Nektar Therapeutics (NKTR)

TIPRANKS
·
14 Jul

Nektar Therapeutics Is Maintained at Buy by B. Riley Securities

Dow Jones
·
09 Jul

U.S. RESEARCH ROUNDUP-Hershey, Metlife, Voya Financial

Reuters
·
08 Jul

Why Nektar Therapeutics Stock Dived by 3% Today

Motley Fool
·
04 Jul

Nektar Therapeutics Closes $115 Million Public Offering with Full Exercise of Underwriters' Option

Reuters
·
03 Jul

BRIEF-Nektar Therapeutics Announces Pricing Of $100 Million Public Offering

Reuters
·
01 Jul

Nektar announces common stock offering, no amount given

TIPRANKS
·
01 Jul

Nektar Therapeutics Files Prospectus for Public Offering to Support Drug Development Initiatives

Reuters
·
01 Jul

Nektar Therapeutics Regains Nasdaq Compliance by June 2025

TIPRANKS
·
28 Jun

Nektar Therapeutics’ Phase 2b Study on Rezpegaldesleukin: A Potential Game-Changer for Atopic Dermatitis

TIPRANKS
·
27 Jun

Why Nektar Therapeutics Stock Was Red-Hot Today

Motley Fool
·
26 Jun

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday

Benzinga
·
26 Jun

Piper Sandler Sticks to Its Buy Rating for Nektar Therapeutics (NKTR)

TIPRANKS
·
25 Jun

U.S. RESEARCH ROUNDUP- Fedex, Omnicom Group, Texas Instruments

Reuters
·
25 Jun

BTIG Raises Nektar Therapeutics' Price Target to $100 From $60, Buy Rating Maintained

MT Newswires Live
·
25 Jun

Nektar price target raised to $100 from $60 at BTIG

TIPRANKS
·
25 Jun

William Blair Sticks to Their Hold Rating for Nektar Therapeutics (NKTR)

TIPRANKS
·
25 Jun